Stockreport

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)

Longboard Pharmaceuticals, Inc.  (LBPH) 
PDF DEEp OCEAN is the first pivotal clinical trial designed to study DEEs broadlyInitial sites activated with additional sites expected to be activated in the coming weeks [Read more]